Supplementary Tables – Infection rates and tolerability of three different immunoglobulin administration modalities in patients with PID

Supplemental Table 1. Participant demographics and baseline characteristics. Supplemental Table 2. Annualized rates of infections by IgG route of administration for subgroup of participants sequentially treated with IVIG, SCIG, and fSCIG and total population from clinical studies. Supplemental Table 3. IgG peak and trough levels by infusion interval. Supplemental Table 4. Causally related AEs (excluding infections). Supplemental Table 5. Causally related AEs (excluding infections) by IgG route of administration for subgroup of participants sequentially treated with IVIG, SCIG, and fSCIG and total population from clinical studies.